descriptionPublicationkeyboard_double_arrow_right Article 01 Aug 2011 English Publisher:SAGE PublicationsJournal:Scottish Medical Journal, volume 56, pages 1-2 (issn: 0036-9330, eissn: 2045-6441,

Authors: M Delicata; H Hambley;

doi: 10.1258/smj.2011.011124

pmid: 21873729

Abnormal activated partial thromboplastin time and malignancy

- Summary
- Subjects
- Metrics

Abstract

Malignancy often results in clotting abnormalities. The aetiology of haemostasis problems in cancer is complex, and is still not completely understood. We describe a case of a patient with malignant mesothelioma, who was found to have elevated activated partial thromboplastin time, due to lupus anticoagulant. We suggest that patients with malignancy should have their coagulation checked prior to any invasive procedures.

Related Organizations

NHS Grampian
United Kingdom
Inverclyde Royal Hospital
United Kingdom
Dr Gray's Hospital
United Kingdom
NHS Greater Glasgow and Clyde
United Kingdom
NHS Grampian
United Kingdom

Keywords

Male, Mesothelioma, Radiography, Humans, Blood Coagulation Tests, Blood Coagulation Disorders, Aged, Thromboplastin

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average